Latest News

Glycan makes moves to the US  |  Jul 22, 2008
Glycan Bioscience, a developer of carbohydrate based drugs for respiratory diseases has made the first transition to the US this month, setting up a lab in New Hampshire in the University town of one of America’s oldest Ivy League colleges, Dartmouth College. Read more of this article >

Stone Ridge makes new key hire to support Biomedical base and expand into Clean-tech  
|  Jul 22, 2008
In February this year, we were very pleased to be able to welcome Andrew Hall to the Stone Ridge team.  Andrew adds a new dimension to the team, with broad expertise within both the Biomedical and Clean tech sectors as an entrepreneur, advisor and investor. Read more of this article >

Lingopal close to launching 1st version of mobile phone translation app.  | Jul 11, 2008
Lingopal (Lingopal Holdings Pty Ltd) is close to launching the first version of their mobile phone translation application, says CEO Richard Johnson. A talking phrase-book for mobile phones, Lingopal gives users the ability to break the ice with foreigners in a convenient, economical and fun way, in multiple languages. Read more of this article >

Orthocell gains approvals for initial human trials  | Aug 31, 2007
Orthocell is one step closer to providing improved treatments for patients suffering from rotator cuff and other tendon injuries having recently gained Australian ethics and regulatory approvals for the initial human trial of their new ATT technology.  These trials will focus on the safety and tolerability of the technology, which uses the patients’ own tissue, for the repair and regeneration of damaged and diseased tendon tissue.  This technology has the potential to deliver the first truly effective regenerative solution for tendonopathy related injuries. Read more of this article >